Роль самостоятельного мониторирования гликемии в комплексном управлении сахарным диабетом типа 2
- Авторы: Черникова Н.А1
-
Учреждения:
- ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва
- Выпуск: Том 16, № 1 (2014)
- Страницы: 63-67
- Раздел: Статьи
- URL: https://ogarev-online.ru/2075-1753/article/view/94055
- ID: 94055
Цитировать
Полный текст
Аннотация
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Н. А Черникова
ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва
Список литературы
- Сунцов Ю.И. Современные сахароснижающие препараты, используемые в России при лечении сахарного диабета типа 2. Сахарный диабет. 2012; 1: 6-10.
- DCCT Research Group: The relationship of a glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-83.
- Klein R. Hyperglycemia and microvascular disease in diabetes. Diabetes Care 1995; 18: 258-68.
- Stratton I.M, Adler A.I, Neil H.A et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
- Bonora E, Calcaterra F, Lombardi S et al. Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes. Diabetes Care 2001; 24: 2023-9.
- Derr R, Garrett E, Stacy G.A, Saudek C.D. Is HbA1c affected by glycemic instability? Diabetes Care 2003; 26: 2728-33.
- Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003; 26: 881-5.
- Funatsu H, Yamashita H, Ohashi Y. Effect of rapid glicaemic control on progression of diabetic retinopathy. Jpn J Ophthalmol 1992; 36 (3): 356-67.
- Boland E, Monsod T, Delucia M et al. Limitations of conventional methods of self - monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24: 1858-62.
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
- Nolan J, Batin Ph.D, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK- HEART). Circulation 1998; 98: 1510-6.
- Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-39.
- ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.
- Kleiger R, Bosner M. Correlation of time and freguence domain measures of heart rate variability. In: Noninvasive Electrocardiology. Clinical aspects of Holter monitoring. Ed.: A.Moss, S.Stern. Saunders Co, University Press. Cambridge UK 1997; p. 199-206.
- Stefanidis A, Asimacopoulos P et al. Intensive insulin treatment reduces transient ischaemic episodes during acute events in diabetic patients. ESC Congress. J Eur Heart 2002; 23: 609.
- Raine C.H et al. Significant Insulin Dose Errors May Occur if Blood Glucose Results are Obtained from Miscoded Meters. Jour Diab Sci Tech 2007; 1(2): 205-10.
Дополнительные файлы
